Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
238 hedge funds and large institutions have $5.46B invested in Syneos Health, Inc. Class A Common Stock in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 112 increasing their positions, 71 reducing their positions, and 35 closing their positions.
503% more call options, than puts
Call options by funds: $6.13M | Put options by funds: $1.02M
65% more capital invested
Capital invested by funds: $3.31B → $5.46B (+$2.15B)
58% more repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 71
4% less funds holding
Funds holding: 247 → 238 (-9)
14% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 35
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
THLTP
Thomas H. Lee (THL) Partners
Boston,
Massachusetts
|
+$1.4B |
| 2 |
AI
Advent International
Boston,
Massachusetts
|
+$1.25B |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$89.7M |
| 4 |
BlackRock
New York
|
+$59.6M |
| 5 |
HM
HealthCor Management
New York
|
+$51.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
-$116M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
-$68.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$32M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$28.2M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$25.2M |
SYNH Hedge Fund Activity: Q3 2017 in Review
238 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q3 2017, worth a combined $5.46B — up 65% from $3.31B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of SYNH and 30 opened new positions — a net loss of 5 holders — while 71 trimmed existing stakes and 112 added.
The largest buyer was Thomas H. Lee (THL) Partners, opening a new position worth an estimated $1.4B. The largest seller was Blue Harbour Group, exiting entirely with an estimated $116M sold.
- 238 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q3 2017, down from 247 in Q2 2017.
- Funds reported $5.46B of Syneos Health, Inc. Class A Common Stock stock for Q3 2017, up 65% quarter-over-quarter.
- 30 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q3 2017 and 35 closed out, a net change of -5 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q3 2017 was Thomas H. Lee (THL) Partners, an estimated $1.4B added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q3 2017 was Blue Harbour Group, an estimated $116M sold.
Based on aggregated 13F filings for Q3 2017.